Glenn Harvey
Illustrator
From this contributor
How long-read sequencing will transform neuroscience
New technology that delivers much more than a simple DNA sequence could have a major impact on brain research, enabling researchers to study transcript diversity, imprinting and more.
How long-read sequencing will transform neuroscience
What kind of autism research should we do, and where should we do it?
Researchers at INSAR 2023 need to discuss these questions and remember that the purpose of research may be different for different communities.
What kind of autism research should we do, and where should we do it?
New measure characterizes gender diversity in study participants
The Gender Self-Report could help autism researchers include more gender-diverse people across a range of ages and neurotypes in their work.
New measure characterizes gender diversity in study participants
Lessons from n-of-1 trials: A conversation with Joseph Gleeson
Some conditions are too rare for conventional drug trials, leading some scientists to test bespoke treatments in single participants. Gleeson discusses the merits — and limitations — of these tiny trials.
Lessons from n-of-1 trials: A conversation with Joseph Gleeson
Debut drug for Rett syndrome at edge of approval
The U.S. Food and Drug Administration plans to make an approval decision on the first-ever drug for girls and women with Rett syndrome by 12 March.
Debut drug for Rett syndrome at edge of approval
Explore more from The Transmitter
Neuroscientists fear Trump’s DEI order may tank diversity-focused grants
Programs that prioritize diversity, equity and inclusion in the field may be at risk, leaving researchers in a “holding pattern,” according to one grant recipient.
Neuroscientists fear Trump’s DEI order may tank diversity-focused grants
Programs that prioritize diversity, equity and inclusion in the field may be at risk, leaving researchers in a “holding pattern,” according to one grant recipient.
Remembering the life of neuropharmacologist Floyd Bloom
The co-author of the classic textbook “The Biochemical Basis of Neuropharmacology” and pioneer in studying the roles of neurotransmitters in the brain died on 8 January at 88 years old.
Remembering the life of neuropharmacologist Floyd Bloom
The co-author of the classic textbook “The Biochemical Basis of Neuropharmacology” and pioneer in studying the roles of neurotransmitters in the brain died on 8 January at 88 years old.
Newly characterized striatal circuits add twist to ‘go/no-go’ model of movement control
The two novel pathways control dopamine release in opposing ways and may link motivation and mood to action, a new study shows.
Newly characterized striatal circuits add twist to ‘go/no-go’ model of movement control
The two novel pathways control dopamine release in opposing ways and may link motivation and mood to action, a new study shows.